A medical researcher monitors blood test results for various diseases, including
ries, they are slow, or both. [Because] growth of microorganisms is associated with carbon dioxide production. . .it is possible to assess microbial growth. The diode laser can be controlled in a few milliseconds, so one detection needs only a few tens to a hundred milliseconds." "I agree that WM-TDLAS monitoring of carbon dioxide is potentially easier than alternative techniques," says Robert Lodder, professor of pharmaceutical science at Kentucky University in Lexington. "WM-TDLAS has been limited in the past by the availability of laser diodes of the proper wavelength. However, the commercial availability situation is changing.
"The trick with monitoring packaged goods (with intact packaging) is getting the light through the package," Lodder continues. "Absorption is a problem. You would have to actually test each individual type of container to determine whether you could collect a usable signal. You also would not want anything in the packaging that scatters the infrared light, which could reduce signals to unusable levels."
Although the cost of using WM-TDLAS-based instruments to monitor microbial growth could be as low as about $0.50 per assay, Lodder suggests that costs would need to be reduced several orders of magnitude further before this approach could be considered "a game changer." 
ZIKA VIRUS

Zika Virus Research Outpaces Commitments To Fund Such Efforts Jeffrey L. Fox
Despite prolonged wrangling over how and how much to fund U.S. research on the Zika virus, the research community is making considerable progress studying this pathogen, quickly confırming its capacity to interfere with fetal development. Beyond careful tracking of this flavivirus and extensive analyses of its structure and genome, recent research efforts focus on understanding its impact on infected individuals, particularly when pregnant, on developing diagnostic tests for the virus, and on vaccine development as well as control of the mosquitoes that spread this virus.
"In less than a year, the status of Zika has changed from a mild medical curiosity to a disease with severe public health implications," said DirectorGeneral Margaret Chan of the World Health Organization (WHO) in Geneva, Switzerland, last March. She also declared the virus "a public health emergency of international concern," one that requires a "coordinated international response." As of March, the virus was detected in at least 38 countries and territories. "If this pattern is confırmed beyond Latin America and the Caribbean," she added, "the world will face a severe public health crisis." Nonetheless, the emergency committee advising WHO on Zika "found no public health justifıcation for restrictions on travel or trade to prevent the spread of Zika virus."
Amid that global call for action against Zika, President Obama and members of the U.S. research and public health communities continued to voice frustration through May as they sought additional resources to investigate the Zika virus and slow its spread. One strategy, namely to repurpose resources intended for Ebola virus for use on Zika, remained stalled last May,
MINITOPIC
Recent Developments in Microbial Diagnosis and Detection
Recent developments in detecting microorganisms include: forcing federal offıcials to scramble for other stopgap funding of $600 million, a good deal short of the $1.9 billion that the Administration sought. "We fınd ourselves in a rare moment where we have advance warning on a disease," a White House offıcial blogged last April. "However, Congress continues to do nothing about the emergency funding."
Public health offıcials say that recent research now convinces them that Zika virus "causes microcephaly"-a link that was considered likely but not conclusive a mere few months earlier. "No single piece of evidence provides conclusive proof that Zika virus infection is a cause of microcephaly and other fetal brain defects," noted Tom Frieden, director of the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., citing a report by Lyle Petersen, Sonja Rasmussen, and others at CDC. "Rather, increasing evidence from a number of recently published studies and a careful evaluation using established scientifıc criteria supports Point-of-care testing appears workable even under highly diffıcult circumstances-specifıcally, when evaluated among women in Papua New Guinea, who are at risk for becoming infected with human papillomavirus, a cause of cervical cancer, according to Andrew Vallely of the University of New South Wales in Sydney, Australia, and his collaborators. Moreover, self-sampling by these women provides specimens that screen as accurately as do cervical samples that clinicians obtained, these investigators note. They call this fınding "critical" for developing same-day, screening-and-treatment procedures for women in this and other developing
